MedPath

Effect of Menstrual Cycle on Traumatic Systemic Response

Not Applicable
Conditions
Systemic Inflammatory Response Syndrome
Interventions
Procedure: modified radical mastectomy
Registration Number
NCT03283345
Lead Sponsor
Kocaeli University
Brief Summary

It is aimed to evaluate pathophysiology of systemic responses to trauma via using interleukin (IL) -1 and IL-6 levels and determining timing of surgery through phases of menstrual cycle.

Detailed Description

89 female breast cancer patient who underwent modified radical mastectomy included into study. Menstrual history and hormone levels were used to determine menstrual phase: luteal, follicular, and other. IL-1β and IL-6 levels, which are related to severeness of inflammation, were measured one day before and one day after surgery. Those are statistically analysed to show effect of timing of breast surgery on responses to trauma in postmenopausal and premenopausal women during different phases of their menstrual cycles

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
89
Inclusion Criteria
  • female patients
  • who underwent modified radical mastectomy for breast cancer
  • who signed informed consent forms
Exclusion Criteria
  • For premenopausal patients taking oral contraceptives
  • for postmenopausal patients taking hormone replacement therapy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
postmenopausal womenmodified radical mastectomypostmenopausal female breast cancer patients who underwent modified radical mastectomy
premenopausal womenmodified radical mastectomypremenopausal female breast cancer patients who underwent modified radical mastectomy
Primary Outcome Measures
NameTimeMethod
IL-1 and IL-6 levels5 month

evaluate pathophysiology of systemic responses to trauma via using IL-1 and IL-6 levels.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath